2025 annual financial data
Aligos Therapeutics 2025 Operating cash flow margin
Direct answer
Operating cash flow margin was -3,774.15%.
Operating income was -87,985,000 USD and net income was -24,193,000 USD.
Operating cash flow was -82,503,000 USD.
Get free Aligos Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,186,000 USD
- Operating income
- -87,985,000 USD
- Net income
- -24,193,000 USD
- Operating cash flow
- -82,503,000 USD